Literature DB >> 3748682

Constipation and meconium ileus equivalent in patients with cystic fibrosis.

S Rubinstein, R Moss, N Lewiston.   

Abstract

Constipation and its complications, particularly meconium ileus equivalent, may become management problems in patients with cystic fibrosis. The medical records of 168 patients with cystic fibrosis were reviewed for the prevalence of constipation and meconium ileus equivalent. Of 168 patients, 54 (32%) had experienced at least one episode of constipation which responded to oral or rectal laxative therapy. In 16 of the study group (9%) meconium ileus equivalent developed. Patients younger than 5 years of age had a lower prevalence and those older than 30 years of age had a much higher prevalence of both conditions. Those with prolonged histories of inadequately controlled steatorrhea appeared to be at higher risk for the eventual development of meconium ileus equivalent. Recurrences and complications of constipation may be avoided by instituting early and aggressive therapy.

Entities:  

Mesh:

Year:  1986        PMID: 3748682

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  18 in total

Review 1.  Control of malabsorption in cystic fibrosis.

Authors:  J M Littlewood; S P Wolfe
Journal:  Paediatr Drugs       Date:  2000 May-Jun       Impact factor: 3.022

Review 2.  Gastrointestinal complications in cystic fibrosis.

Authors:  J M Littlewood
Journal:  J R Soc Med       Date:  1992       Impact factor: 5.344

Review 3.  Urinary incontinence in cystic fibrosis.

Authors:  Mary E Dodd; Hannah Langman
Journal:  J R Soc Med       Date:  2005       Impact factor: 5.344

4.  Iron supplementation does not worsen respiratory health or alter the sputum microbiome in cystic fibrosis.

Authors:  Alex H Gifford; Diana M Alexandru; Zhigang Li; Dana B Dorman; Lisa A Moulton; Katherine E Price; Thomas H Hampton; Mitchell L Sogin; Jonathan B Zuckerman; H Worth Parker; Bruce A Stanton; George A O'Toole
Journal:  J Cyst Fibros       Date:  2013-12-13       Impact factor: 5.482

5.  Intraoperative intraluminal injection of N-acetylcysteine allowing treatment of distal intestinal obstruction syndrome without the need for enterotomy.

Authors:  Nicholas Js Chilvers; James Wheeler
Journal:  BMJ Case Rep       Date:  2018-05-16

Review 6.  Abdominal pain in cystic fibrosis.

Authors:  J M Littlewood
Journal:  J R Soc Med       Date:  1995       Impact factor: 5.344

7.  [Emergencies in adult mucoviscidosis patients].

Authors:  C Smaczny; T Born; T O F Wagner
Journal:  Internist (Berl)       Date:  2012-05       Impact factor: 0.743

Review 8.  Pancreatic exocrine function in patients with cystic fibrosis.

Authors:  Susan S Baker; Drucy Borowitz; Robert D Baker
Journal:  Curr Gastroenterol Rep       Date:  2005-06

Review 9.  Cystic fibrosis.

Authors:  Felix Ratjen; Scott C Bell; Steven M Rowe; Christopher H Goss; Alexandra L Quittner; Andrew Bush
Journal:  Nat Rev Dis Primers       Date:  2015-05-14       Impact factor: 52.329

10.  Treatment of Gastrointestinal Problems in Cystic Fibrosis.

Authors:  Maria R. Mascarenhas
Journal:  Curr Treat Options Gastroenterol       Date:  2003-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.